医学
危险系数
内科学
中性粒细胞与淋巴细胞比率
荟萃分析
胰腺癌
肿瘤科
癌症
淋巴细胞
梅德林
出版偏见
胃肠病学
置信区间
政治学
法学
作者
Nicholas Mowbray,David Griffith,Mohammed Hammoda,Guy Shingler,Amir Kambal,Bilal Al-Sarireh
出处
期刊:Hpb
[Elsevier]
日期:2018-05-01
卷期号:20 (5): 379-384
被引量:40
标识
DOI:10.1016/j.hpb.2017.12.009
摘要
BackgroundThe neutrophil-to-lymphocyte ratio (NLR) is thought to reflect cancer disease burden. To assess the prognostic ability of the NLR on overall survival in patients with resectable, pancreatic cancer a meta-analysis of published literature was undertaken.MethodA systematic review was performed independently by two authors using PubMed, Ovid MEDLINE and Embase databases. Included studies detailed the pre-operative NLR and overall survival of pancreatic cancer patients.ResultsOf the 214 studies retrieved using the search strategy, 8 studies involving 1519 patients were included in the meta-analysis. Only one study did not find a statistically significant association between a high NLR and OS. The pooled Hazard Ratio was 1.77 (95% CI [1.45–2.15]; p < 0.01). The NLR cut-off values ranged from 2 to 5. There was low to moderate inter-study heterogeneity (I2 = 31%; p = 0.17), a low risk of intra-study bias, and potentially 3 unpublished (negative) studies.ConclusionsA high pre-operative NLR indicates a worse prognosis than in patients with a low NLR. There is potential to use the NLR to direct therapies. A specific cut-off value has not been established from this study and so further research is required.
科研通智能强力驱动
Strongly Powered by AbleSci AI